Señales en vivo de 6622.HK | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 04:08):

Stats
Volumen de hoy	964 145
Volumen promedio	580 496
Capitalización de mercado	830.13M
EPS	HKD0 ( 2024-03-27 )
Próxima fecha de ganancias	( HKD0 ) 2024-05-24
Last Dividend	HKD0 ( N/A )
Next Dividend	HKD0 ( N/A )
P/E	-1.970
ATR14	HKD0.00800 (0.53%)

Volumen Correlación

Largo: -0.14 (neutral)

Corto: -0.48 (neutral)

Signal:(45.975) Neutral

Zhaoke Ophthalmology Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Zhaoke Ophthalmology Correlación - Moneda/Commodity

0.33
( neutral )

0.57
( weak )

0.00
( neutral )

0.53
( weak )

-0.67
( moderate negative )

-0.61
( weak negative )

Zhaoke Ophthalmology Finanzas

Annual	2023
Ingresos:	HKD18.75M
Beneficio Bruto:	HKD14.25M (75.98 %)
EPS:	HKD-0.710

FY	2023
Ingresos:	HKD18.75M
Beneficio Bruto:	HKD14.25M (75.98 %)
EPS:	HKD-0.710

FY	2022
Ingresos:	HKD0
Beneficio Bruto:	HKD0 (0.00 %)
EPS:	HKD-0.760

FY	2021
Ingresos:	HKD0.00
Beneficio Bruto:	HKD0.00 (0.00 %)
EPS:	HKD-3.98

Financial Reports:

No articles found.

Zhaoke Ophthalmology

Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, and commercialization of therapies that address unmet medical needs in the People's Republic of China. It is developing various drugs that cover ophthalmic indications affecting the anterior and posterior segments, including dry eye diseases, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma. The company was formerly known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was incorporated in 2017 and is headquartered in Guangzhou, the People's Republic of China.